Turning Insight into Impact

BioInfect brings together experts from across research, biotech, pharma, healthcare, clinical practice and policy to explore one of the most significant challenges facing global health: antimicrobial resistance (AMR). Through expert insight, industry perspectives and valuable networking opportunities, the conference provides a forum for collaboration, knowledge sharing and action.

With AMR continuing to rise worldwide, solutions will only be found through cross-sector engagement and innovation. BioInfect offers a unique opportunity to connect with those developing new approaches to prevention, diagnosis, surveillance and treatment, while helping shape the future direction of the conversation.

Addressing the AMR challenge

Antimicrobial resistance remains one of the most pressing public health challenges of our time. The growing spread of resistant infections threatens the effectiveness of existing treatments and increases the risk of routine procedures, cancer therapies and other essential medical interventions.

BioInfect provides a platform for the organisations, researchers, clinicians, innovators and policymakers working to tackle this challenge. Whether you are developing new technologies, advancing research, supporting translation and commercialisation, or helping shape policy, the conference offers an opportunity to engage with the latest thinking, build new connections and contribute to the collective effort against AMR.